COMMUNIQUÉS West-GlobeNewswire

Le personnel infirmier en déficit d’activité physique, selon une étude
27/03/2018
OTTAWA, 27 mars 2018 (GLOBE NEWSWIRE) -- L’inquiétante proportion du personnel infirmier du Canada rapportant un état de santé médiocre signale que leur mode de vie ne serait pas suffisamment sain et qu’il serait en [...]
Claus Frisenberg Pedersen, CFO in Oncology Venture buys shares in Oncology Venture and MPI
27/03/2018
Hoersholm, Denmark - March 27, 2018 - Oncology Venture Sweden AB (OV:ST) ("Oncology Venture") and Medical Prognosis Institute (MPI.ST) ("MPI") announces that Claus Frisenberg Pedersen, CCO and CFO in Oncology Venture, [...]
EZBIS Partners with ABILITY Network to Help Chiropractic Providers Simplify Revenue Cycle Management
27/03/2018
MINNEAPOLIS, March 27, 2018 (GLOBE NEWSWIRE) -- ABILITY ® Network, a leading healthcare information technology company, and EZBIS, Inc., the nation’s foremost provider of comprehensive chiropractic software, today [...]
Metabolon and DIAN Open New Metabolomics Laboratory in China
27/03/2018
RESEARCH TRIANGLE PARK, N.C., March 27, 2018 (GLOBE NEWSWIRE) -- Metabolon, Inc. , the global leader in metabolomics, announced today that its joint metabolomics laboratory with Zhejiang Dian Diagnostics Co., Ltd. (“ [...]
HIFU for Prostate Cancer Now Available at Baptist Health Louisville in Kentucky
27/03/2018
CHARLOTTE, N.C., March 27, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC, the leading provider of HIFU technology to physician practices in the United States, announced today that they have partnered with Baptist [...]
Wildflower’s California Acquisition Moves Forward After Completion of Due Diligence
27/03/2018
VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- Wildflower Marijuana Inc. (CSE:SUN) (FWB:RSP) (“Wildflower” or the "Company") has completed its due diligence and is on schedule for the purchase of [...]
PotNetwork Holding Inc. Releases First Corporate Video Highlighting Its Success in the CBD Oil Industry
27/03/2018
FT LAUDERDALE, Fla., March 27, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holding, Inc. (OTC Pink:POTN) On Tuesday, March 27th, 2018, PotNetwork Holding Inc. announces the release of its first corporate [...]
Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic Resistance
27/03/2018
TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced today that the U.S. Patent and Trademark Office has issued U.S. Patent 9,925,206 [...]
Survey: People Turning to Online Mental Health Resources as Stigma Runs Rampant Among Workplaces, Schools, Communities
27/03/2018
NEW YORK , March 27, 2018 (GLOBE NEWSWIRE) -- IntrusiveThoughts.org, a non-profit organization and website that humanizes the experience of living with Obsessive-Compulsive Disorder (OCD) and other mental illnesses, [...]
Medecision Launches Aerial CarePlanner 360™, the Latest Release in Suite of Advanced Care Management Solutions
27/03/2018
DALLAS, March 27, 2018 (GLOBE NEWSWIRE) -- Medecision , the leader in population health management solutions for risk-bearing entities, announced today it has launched its newest application from the company’s [...]
Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors
27/03/2018
CRANBURY, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ: ONS ) today announced the appointment of Joerg Windisch, Ph.D. to its board of directors, effective March 23, 2018. In addition, [...]
BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds
27/03/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (" BriaCell " or the " Company ") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology [...]
Agritek Holdings, Inc. Comments On Passage Of U.S. Consolidated Appropriations Act Of 2018 Retaining State Medical Marijuana Protections As Company Increases Equity Stakes In Colorado and Puerto Rico Cultivation Operations
27/03/2018
LOS ANGELES, CA, March 27, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Golden Leaf Holdings Signs Letter of Intent with BlackShire Capital to Launch Chalice Farms Franchise Model
27/03/2018
TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced [...]
Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
27/03/2018
Celsion Enters 2018 with Solid Fundamentals, a Strong Balance Sheet and an Advancing Clinical Pipeline Company to Hold Conference Call on Tuesday, March 27, 2018 at 11:00 a.m. EDT LAWRENCEVILLE, N.J., March 27, 2018 ( [...]
Summit Therapeutics Announces the Results of Placing and Issue of Equity
27/03/2018
This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, the Republic of South Africa or any jurisdiction where to do so might [...]
AveXis Gene Therapy Awarded SAKIGAKE Designation for Spinal Muscular Atrophy Type 1
27/03/2018
CHICAGO, March 27, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
Karmanos Cancer Institute, first cancer center in Michigan to offer CAR-T Therapy for an aggressive type of non-Hodgkin Lymphoma
27/03/2018
DETROIT, March 27, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute in Detroit is the first center in Michigan approved to treat adult patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL) [...]
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection
27/03/2018
NasoVAX intranasal influenza vaccine demonstrated strong cellular immune response and 100% seroprotection HepTcell vaccine was well tolerated but T-cell immunogenicity results were inconclusive GAITHERSBURG, Md., March [...]

Pages